Study of in vitro and in vivo effect of docosahexaenoic acid on rat C6 glioma

Journal of Experimental Therapeutics and Oncology

Volumn 8, Issue 2, 2009, Pages 95-103

  Nasrollahzadeh, Javad ^a   Siassi, Fereydoun ^b   Doosti, Mahmood ^c   Eshraghian, Mohammad Reza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C6 glioma; Docosahexaenoic acid; p21; Rat; Survival

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; LINOLEIC ACID; LOMUSTINE; MESSENGER RNA; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLIOMA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIET; DOCOSAHEXAENOIC ACIDS; EATING; FATTY ACIDS; FEMALE; GLIOMA; LINOLEIC ACID; NEOPLASM TRANSPLANTATION; P21-ACTIVATED KINASES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 74049128956     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hardman WE. (n-3) fatty acids and cancer therapy. J Nutr 134: 3427S-3430S, 2004.
2. Dupertuis YM, Meguid MM, Pichard C. Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 10: 427-32, 2007.
3. Bougnoux P. n-3 polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care 2: 121-6, 1999.
4. Biondo PD, Brindley DN, Sawyer MB, Field CJ. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutr Biochem 19: 787-96, 2008.
5. Pardini RS. Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem Biol Interact 162: 89-105, 2006.
6. Vartak S, Robbins ME, Spector AA. Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipids 32: 283-92, 1997.
7. Leonardi F, Attorri L, Di Benedetto R, Di Biase A, Sanchez M, Nardini M, Salvati S. Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells. Free Radic Res 39: 865-74, 2005.
8. Connor WE, Neuringer M, Reisbick S. Essential fatty acids: the importance of n-3 fatty acids in the retina and brain. Nutr Rev 50: 21-9, 1992.
9. Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aid S, Poumes-Ballihaut C, Champeil-Potokar G, Lavialle M. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 44: 509-38, 2004.
10. Martin DD, Robbins ME, Spector AA, Wen BC, Hussey DH. The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue. Lipids 31: 1283-8, 1996.
11. Kokoglu E, Tuter Y, Yazici Z, Sandikci KS, Sonmez H, Ulakoglu EZ, Ozyurt E. Profiles of the fatty acids in the plasma membrane of human brain tumors. Cancer Biochem Biophys 16: 301-12, 1998.
12. Qi K, Hall M, Deckelbaum RJ. Long-chain polyunsaturated fatty acid accretion in brain. Curr Opin Clin Nutr Metab Care 5: 133-8, 2002.
13. Sinclair AJ. Incorporation of radioactive polyunsaturated fatty acids into liver and brain of developing rat. Lipids 10: 175-84, 1975.
14. Igarashi M, DeMar JC, Jr., Ma K, Chang L, Bell JM, Rapoport SI. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J Lipid Res 48: 1150-8, 2007.
15. Rapoport SI, Chang MC, Spector AA. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 42: 678-85, 2001.
16. Nasrollahzadeh J, Siassi F, Doosti M, Eshraghian MR, Shokri F, Modarressi MH, Mohammadi-Asl J, Abdi K, Nikmanesh A, Karimian SM. The influence of feeding linoleic, gamma-linolenic and docosahexaenoic acid rich oils on rat brain tumor fatty acids composition and fatty acid binding protein 7 mRNA expression. Lipids Health Dis 7: 45, 2008.
17. Chapkin RS, Seo J, McMurray DN, Lupton JR. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem Phys Lipids 153: 14-23, 2008.
18. Yavin E. Docosahexaenoic acid: a pluripotent molecule acting as a membrane fluidizer, a cellular antioxidant and a modulator of gene expression. Nutr Health 18: 261-2, 2006.
19. Verlengia R, Gorjao R, Kanunfre CC, Bordin S, Martins De Lima T, Martins EF, Curi R. Comparative effects of eicosapentaenoic acid and docosahexaenoic acid on proliferation, cytokine production, and pleiotropic gene expression in Jurkat cells. J Nutr Biochem 15: 657-65, 2004.
20. Narayanan BA, Narayanan NK, Reddy BS. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 19: 1255-62, 2001.
21. Das UN. Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukot Essent Fatty Acids 61: 157-63, 1999.
22. Sherr CJ. Cancer cell cycles. Science 274: 1672-7, 1996.
23. Khan NA, Nishimura K, Aires V, Yamashita T, Oaxaca-Castillo D, Kashiwagi K, Igarashi K. Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation. J Lipid Res 47: 2306-13, 2006.
24. Crim KC, Sanders LM, Hong MY, Taddeo SS, Turner ND, Chapkin RS, Lupton JR. Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet. Carcinogenesis 29: 1415-20, 2008.
25. Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DP, Darzynkiewicz Z. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Cancer Res 60: 4139-45, 2000.
26. Plumb JA. Cell sensitivity assay: The MTT assay. In: Langdon SP (ed) Cancer Cell Cultures: Methods and Protocols. Humana Press, Totowa,NJ, 2004, pp 165-169.
27. Mansky PJ, Duic JP, Fine HA. Central Nervous System Tumors. In: Abraham J, Gulley JL and Allegra CJ (eds). Bethesda Handbook of Clinical Oncology. Lippincott Williams & Wilkins, 2005, pp 433-453.
28. Tamura M, Mennel HD, Zulch KJ. Brain tumor chemotherapy using a rat glioma model. J Cancer Res Clin Oncol 94: 39-46, 1979.
29. Vince GH, Bendszus M, Schweitzer T, Goldbrunner RH, Hildebrandt S, Tilgner J, Klein R, Solymosi L, Christian Tonn J, Roosen K. Spontaneous regression of experimental gliomas - an immunohistochemical and MRI study of the C6 glioma spheroid implantation model. Exp Neurol 190: 478-85, 2004.
30. Marshall OJ. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 20: 2471-2, 2004.
31. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36, 2002.
32. Sheehan J, Ionescu A, Pouratian N, Hamilton DK, Schlesinger D, Oskouian RJ, Jr., Sansur C. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation. J Neurosurg 108: 972-8, 2008.
33. Leonardi F, Attorri L, Benedetto RD, Biase AD, Sanchez M, Tregno FP, Nardini M, Salvati S. Docosahexaenoic acid supplementation induces dose and time dependent oxidative changes in C6 glioma cells. Free Radic Res 41: 748-56, 2007.
34. Chen ZY, Istfan NW. Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostaglandins Leukot Essent Fatty Acids 64: 67-73, 2001.
35. Massague J. G1 cell-cycle control and cancer. Nature 432: 298-306, 2004.
36. Yusufi AN, Cheng J, Thompson MA, Walker HJ, Gray CE, Warner GM, Grande JP. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells. J Lab Clin Med 141: 318-29, 2003.
37. Das UN: Gamma-linolenic acid therapy of human glioma-a review of in vitro, in vivo, and clinical studies. Med Sci Monit 13: RA119-31, 2007.
38. Leaver HA, Wharton SB, Bell HS, Leaver-Yap IM, Whittle IR. Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of gamma linolenic acid in an implantation glioma model: effects on tumour biomass, apoptosis and neuronal tissue histology. Prostaglandins Leukot Essent Fatty Acids 67: 283-92, 2002.
39. Marsh J, Mukherjee P, Seyfried TN. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma. Clin Cancer Res 14: 7751-62, 2008.
40. Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer 86: 1615-21, 2002.
41. Colas S, Paon L, Denis F, Prat M, Louisot P, Hoinard C, Le Floch O, Ogilvie G, Bougnoux P. Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid. Int J Cancer 109: 449-54, 2004.